Founded on June 18, 1973.
Its basic study areas are:
- genomics, proteomics, bioinformatics, gene and cellular engineering.
Principal achievements and developments:
Institute's scientists published over 4000 papers, of those more than 500 were published in renowned foreign journals. They secured 200 author's certificates. The Institute hosted about 70 conferences, meetings, science schools etc.
Novel biotechnologies developed at the Institute:
Test systems for gene diagnostics of severe hereditary diseases and hereditary susceptibility to mass pathologies (L. Livshits, Prof., Dr. Biol.); Molecular diagnostics of chronic myelogenous and acute lymphoblastic leukemias, using PCR and specific polyclonal antibodies (S. Maliuta, Prof., Dr. Biol., NAS Corr. Memb.); Large-scale search for epithelial tumor biomarkers (A. Rynditch, Prof.,Dr. Biol., NAS Corr. Memb.); Identification of tumour-associated antigens for the development of advanced immunological approaches to cancer diagnostics and treatment (V. Filonenko, Prof., Dr. Biol.); New anticancer and antiviral medications (A. Potopalsky, Senior Sci., Cand. Biol.); Molecular modeling and drug design: development of protein kinase inhibitors (S. Yarmoluk, Prof., Dr. Biol.); Structure-based discovery of drugs against pathogenic bacteria (M.Tukalo, Prof., Dr. Biol.); Production of a novel antiangiogenic cytokine - C-module of tyrosyl-tRNA synthetase ('Cendomap') (O.Kornelyuk, Prof., Dr.Biol., NAS Corr. Memb.); Baculovirus expression system for obtaining recombinant proteins (O. Solomko, Prof., Dr. Biol.); A biotechnology for producing plant secondary metabolites (S. Maliuta, Prof., Dr. Biol., NAS Corr. Memb.); Application of lectins from medicinal plants for biomedical research (I. Karpova, Senior Sci., Cand. Biol.); Antimycobacterial agents (A. Shved, Senior Sci., Dr. Biol.); Production of Rauwolfia serpentina benth cultured cell biomass with high ajmaline content as a source of antiarrhythmic & hypotensive medications (V. Kunakh, Prof., Dr. Biol., NAS Corr. Memb.); Cell biotechnology of Ungernia victoris (V. Kunakh, Prof., Dr. Biol., NAS Corr. Memb.); Production of Panax ginseng cell biomass (V. Kunakh, Prof., Dr. Biol., NAS Corr. Memb.); Development of skin equivalents on the base of human stem cells cultivated on special media in vitro for treatment of massive burns (L. Lukash, Senior Sci., Dr. Biol.); Gene and Cell Therapy (V. Kordium, Prof., Dr. Med., NAS Corr. Member, AMSU Acad.); KLEPS bacterial inoculant (N. Kozyrovska, Senior Sci., Cand. Biol.); Express-method for authentication of Klebsiella oxytoca IMBG26 on the PCR basis (N. Kozyrovska, Senior Sci., Cand. Biol.); Development and production of electrochemical and optical biosensors for medicine (A. Elska, Prof., Dr. Biol., NAS Acad., O. Soldatkin, Prof., Dr. Sci.); Development and production of analytical devices based on electrochemical mono- and multibiosensors for environment monitoring (A. Elska, Prof., Dr. Biol., NAS Acad., S. Dzyadevych, Senior Sci., Dr. Sci.); Development and production of electrochemical biosensors for biotechnological processes and foodstuff control (O. Soldatkin, Prof., Dr. Sci., S. Dziadevych, Senior Sci., Dr. Sci.).
